James Radke, Rare Disease ReportSep 1, 20171 minSenator Orrin Hatch Introduces the OPEN ACT of 2017The OPEN ACT, introduced by Sen. Orin Hatch of Utah, would provide incentives to pharmaceutical companies to repurpose already approved dru
Reid d"AmicoJun 26, 20171 minChronic Disease Communities’ Voices Need to Be Heard in the Halls of PowerChronic disease patients, who invest a great deal of time in the medical system, must apply pressure on legislators to improve access and tr